APA (7th ed.) Citation

F, A., J, D., C, D., P, K., C, R., N, S., . . . JB, M. (2024). TG6050, an oncolytic vaccinia virus encoding interleukin-12 and anti-CTLA-4 antibody, favors tumor regression via profound immune remodeling of the tumor microenvironment. Journal for immunotherapy of cancer, 12(7), . https://doi.org/10.1136/jitc-2024-009302

Chicago Style (17th ed.) Citation

F, Azar, et al. "TG6050, an Oncolytic Vaccinia Virus Encoding Interleukin-12 and Anti-CTLA-4 Antibody, Favors Tumor Regression via Profound Immune Remodeling of the Tumor Microenvironment." Journal for Immunotherapy of Cancer 12, no. 7 (2024). https://doi.org/10.1136/jitc-2024-009302.

MLA (9th ed.) Citation

F, Azar, et al. "TG6050, an Oncolytic Vaccinia Virus Encoding Interleukin-12 and Anti-CTLA-4 Antibody, Favors Tumor Regression via Profound Immune Remodeling of the Tumor Microenvironment." Journal for Immunotherapy of Cancer, vol. 12, no. 7, 2024, https://doi.org/10.1136/jitc-2024-009302.